Saeed Mohammadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saeed Mohammadi has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Zarei
Department of Physiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
8 shared publications Mohammad Zarei
Department of Physiology, School of Medicine, Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
6 shared publications- Sajjad Jabbari
Department of Biology, Faculty of Sciences, Islamic Azad University, Tehran North Branch, Tehran, Iran
6 shared publications - Zainul Amiruddin Zakaria
Borneo Research on Algesia, Inflammation and Neurodegeneration (BRAIN) Group, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
6 shared publications - Donya Ziafatdoost Abed
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
3 shared publications - Alireza Komaki
Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2 shared publications
Latest Publications
- Open Access
- 18 May 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (6) , 200
Rhamnazin attenuates Amyloid β-Peptide (1–42) induced spatial memory impairments by modulation of BDNF-ERK signaling pathway
Rhamnazin (Rham), a natural flavonoid, possesses various medicinal benefits including anti-inflammatory, antioxidant, antiangiogenic, and antibacterial activities. Additionally, Rham showed neuroprotective effects when assessed using the chronic stress-induced cognitive impairment assay. In this intriguing investigation, researchers delved into the working memory and spatial reference memory of Rham, utilizing a rat model of Alzheimer’s disease (AD) induced by amyloid β1-42 (Aβ1-42). Administering Aβ1-42 directly into the ventricles led to notable cognitive impairments in behavioral assessments of rats with AD. However, chronic treatment of Rham (30, 60, and 120 mg/kg) once per day during five consecutive days improved the cognitive functions of AD-induced rats in a dose-dependent manner which was not observed following the acute Rham treatment. Concurrently, Rham administration also increased the levels of BDNF and phosphorylated ERK in the hippocampus. Moreover, the cognitive boost triggered by Rham was replicated through the overproduction of BDNF in the hippocampus. However, this effect was thwarted by either the bilateral delivery of lentiviruses expressing BDNF shRNA into the hippocampus or by a targeted injection of an ERK inhibitor. In conclusion, chronic treatment with Rham improves the cognitive deficits in AD-induced rats possibly via the upregulation of BDNF/ERK signaling pathway in hippocampus.
- 18 May 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (6) , 200
Open AccessRhamnazin attenuates Amyloid β-Peptide (1–42) induced spatial memory impairments by modulation of BDNF-ERK signaling pathway
Rhamnazin (Rham), a natural flavonoid, possesses various medicinal benefits including anti-inflammatory, antioxidant, antiangiogenic, and antibacterial activities. Additionally, Rham showed neuroprotective effects when assessed using the chronic stress-induced cognitive impairment assay. In this intriguing investigation, researchers delved into the working memory and spatial reference memory of Rham, utilizing a rat model of Alzheimer’s disease (AD) induced by amyloid β1-42 (Aβ1-42). Administering Aβ1-42 directly into the ventricles led to notable cognitive impairments in behavioral assessments of rats with AD. However, chronic treatment of Rham (30, 60, and 120 mg/kg) once per day during five consecutive days improved the cognitive functions of AD-induced rats in a dose-dependent manner which was not observed following the acute Rham treatment. Concurrently, Rham administration also increased the levels of BDNF and phosphorylated ERK in the hippocampus. Moreover, the cognitive boost triggered by Rham was replicated through the overproduction of BDNF in the hippocampus. However, this effect was thwarted by either the bilateral delivery of lentiviruses expressing BDNF shRNA into the hippocampus or by a targeted injection of an ERK inhibitor. In conclusion, chronic treatment with Rham improves the cognitive deficits in AD-induced rats possibly via the upregulation of BDNF/ERK signaling pathway in hippocampus.
- 28 November 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 339, 119174
Antinociceptive, antineuropathic, and antimigraine-like activities of Fritillaria imperialis L. rich in verticinone on rats: Mechanisms of action
- 28 November 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 339, 119174
Antinociceptive, antineuropathic, and antimigraine-like activities of Fritillaria imperialis L. rich in verticinone on rats: Mechanisms of action
- 4 October 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 2) , 118913
Antinociceptive and antineuropathic effects of Trifolium resupinatum L. on formalin-induced nociception and cervical spinal cord hemi-contusion: Underlying Mechanisms
- 4 October 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 337 (Pt 2) , 118913
Antinociceptive and antineuropathic effects of Trifolium resupinatum L. on formalin-induced nociception and cervical spinal cord hemi-contusion: Underlying Mechanisms
- 4 October 2023
- Published by Springer Nature in Inflammopharmacology
- Vol. 31 (6) , 3203-3216
Effects of Chaerophyllum macropodum Boiss. leaves essential oil in inflammatory and neuropathic pain: uncovering the possible mechanism of action
Background Chaerophyllum macropodum Boiss. (popularly known as “Jafari farangi kohestani”) is a predominant medicinal plant traditionally utilized in the treatments of peritoneal inflammation and headache in Persian folk medicine. Here, we have revealed the anti-neuropathic and anti-nociceptive activities of C. macropodum leaves essential oil (CMEO) in addition to uncovering the possible mechanisms of action. Methods Formalin-induced paw licking model was used to assess the anti-nociceptive activity of CMEO and its major constituent, terpinolene (TP). The anti-nociceptive activity of these compounds was determined by investigating the roles of various non-opioid and NO-cGMP-K+ channels. Additionally, the anti-neuropathic potential of CMEO and TP was determined using cervical spinal cord contusion/CCS technique. Results The CMEO exerted significant anti-nociceptive activity with a remarkable activity seen in the second phase of formalin-induced paw licking model and this activity were remarkably reversed by pre-treatment of naloxone (an opioid antagonist). Pretreatment with several types of NO-cGMP-potassium channel pathway meaningfully reversed the anti-nociceptive potential of CMEO in phase II of formalin model. Moreover, pre-treatment with several antagonists of non-opioid receptors revealed that only the antagonist of TRPV-1, serotonin type 3, 5-HT2, α2 adrenergic, and CB1 receptors (capsaicin, ondansetron, ketanserin, yohimbine, and SR141716A, respectively) reversed CMEO anti-nociception. CMEO and TP also remarkably reversed hyperalgesia and mechanical allodynia in the CCS technique. Conclusion The CMEO exerts anti-nociceptive and anti-neuropathic activities via the modulation of NO-cGMP potassium channel pathway, opioid as well as several non-opioid receptor activity. TP might partly contribute to the observed activities of CMEO. Graphical abstract
- 4 October 2023
- Published by Springer Nature in Inflammopharmacology
- Vol. 31 (6) , 3203-3216
Effects of Chaerophyllum macropodum Boiss. leaves essential oil in inflammatory and neuropathic pain: uncovering the possible mechanism of action
Background Chaerophyllum macropodum Boiss. (popularly known as “Jafari farangi kohestani”) is a predominant medicinal plant traditionally utilized in the treatments of peritoneal inflammation and headache in Persian folk medicine. Here, we have revealed the anti-neuropathic and anti-nociceptive activities of C. macropodum leaves essential oil (CMEO) in addition to uncovering the possible mechanisms of action. Methods Formalin-induced paw licking model was used to assess the anti-nociceptive activity of CMEO and its major constituent, terpinolene (TP). The anti-nociceptive activity of these compounds was determined by investigating the roles of various non-opioid and NO-cGMP-K+ channels. Additionally, the anti-neuropathic potential of CMEO and TP was determined using cervical spinal cord contusion/CCS technique. Results The CMEO exerted significant anti-nociceptive activity with a remarkable activity seen in the second phase of formalin-induced paw licking model and this activity were remarkably reversed by pre-treatment of naloxone (an opioid antagonist). Pretreatment with several types of NO-cGMP-potassium channel pathway meaningfully reversed the anti-nociceptive potential of CMEO in phase II of formalin model. Moreover, pre-treatment with several antagonists of non-opioid receptors revealed that only the antagonist of TRPV-1, serotonin type 3, 5-HT2, α2 adrenergic, and CB1 receptors (capsaicin, ondansetron, ketanserin, yohimbine, and SR141716A, respectively) reversed CMEO anti-nociception. CMEO and TP also remarkably reversed hyperalgesia and mechanical allodynia in the CCS technique. Conclusion The CMEO exerts anti-nociceptive and anti-neuropathic activities via the modulation of NO-cGMP potassium channel pathway, opioid as well as several non-opioid receptor activity. TP might partly contribute to the observed activities of CMEO. Graphical abstract
- 20 September 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 1) , 117181
The oral administration of Lotus corniculatus L. attenuates acute and chronic pain models in male rats
- 20 September 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 1) , 117181
The oral administration of Lotus corniculatus L. attenuates acute and chronic pain models in male rats
- 22 August 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115638
Insight into the possible mechanism(s) involved in the antinociceptive and antineuropathic activity of Descurainia sophia L. Webb ex Prantl essential oil
- 22 August 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 298, 115638
Insight into the possible mechanism(s) involved in the antinociceptive and antineuropathic activity of Descurainia sophia L. Webb ex Prantl essential oil
- 5 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- p. 114957
WITHDRAWN: Physospermum cornubiense L. alleviates nociceptive and neuropathic pain: Evidences and possible mechanisms
- 5 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- p. 114957
WITHDRAWN: Physospermum cornubiense L. alleviates nociceptive and neuropathic pain: Evidences and possible mechanisms
- 1 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 283, 114695
Thymus persicus (Ronniger ex Rech. f.) Jalas alleviates nociceptive and neuropathic pain behavior in mice: Multiple mechanisms of action
- 1 January 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 283, 114695
Thymus persicus (Ronniger ex Rech. f.) Jalas alleviates nociceptive and neuropathic pain behavior in mice: Multiple mechanisms of action
- 1 June 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 273, 113990
Bupleurum falcatum L. alleviates nociceptive and neuropathic pain: Potential mechanisms of action
- 1 June 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 273, 113990
Bupleurum falcatum L. alleviates nociceptive and neuropathic pain: Potential mechanisms of action
- 1 March 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 268, 113604
Artemisia biennis Willd.: Anti-Nociceptive effects and possible mechanisms of action
- 1 March 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 268, 113604
Artemisia biennis Willd.: Anti-Nociceptive effects and possible mechanisms of action